Molecular Surveillance and Prediction of Antimicrobial Resistance of Neisseria gonorrhoeae in Northern Alberta, Canada, 2015 to 2018. Issue 5 (24th May 2022)

• Record Type: Journal Article
• Authors: Pilkie, Daralynn; Gratrix, Jennifer; Sawatzky, Pam; Martin, Irene; Singh, Ameeta; Prasad, Errol; Naidu, Prenilla; Mulvey, Michael; Wong, Tom; Smyczek, Petra Andrea
• Is Part Of: Sexually transmitted diseases. Volume 49:Issue 5(2022)
• Page Start: 377
• Page End: 382
• Publication Date: 2022-05-24
• Subjects: Sexually transmitted diseases -- Periodicals; Sexual health -- Periodicals; 616.951005
• DOI: 10.1097/OLQ.0000000000001604
• Languages: English
• ISSNs: 0148-5717

Abstract

Abstract : Multiantigen sequence typing in combination with single-nucleotide polymorphism assay and/or whole-genome sequencing can be used as a surrogate to predict antibiotic resistance in Neisseria gonorrhoeae . Abstract : Background: The aims of this study was to describe molecular surveillance of Neisseria gonorrhoeae in the North Zone of Alberta (NZ) and to determine its value in predicting antimicrobial resistance. Methods: Sequence types (STs) and single-nucleotide polymorphism (SNP) assays were performed on nucleic acid amplification testing (NAAT) samples. Sequence types of NAATs were matched to ST of cultures from across Alberta. Antimicrobial resistance prediction of NAATs for cephalosporins, azithromycin, and ciprofloxacin using SNP was compared with matching ST culture results using agar dilution and whole-genome sequencing. Results: Of 2755 eligible specimens (2492 cases), 61.9% (1646 specimens) were sent for sequence typing, identifying 196 unique ST. Antimicrobial resistance data for 1307 additional cases were available using matching cultures. Decreased susceptibility (DS) to antimicrobials used for gonorrhea treatment was rare in the NZ; according to the SNP assay, none of the specimens had predicted DS to cephalosporins or azithromycin resistance. However, of the NZ NAAT samples tested in this study, 10.7% (131 of 1220) were predicted to have intermediate cephalosporin minimum inhibitory concentrations and 9.6% (115 of 1204) were resistant to ciprofloxacin. Based on cultures, the proportions of resistance in all of Alberta were as follows: DS to cephalosporins, 0.6% (20 of 3373); DS to intermediate cephalosporin, 16.9% (570 of 3373); azithromycin resistance, 1.2% (41 of 3373); and ciprofloxacin resistance, 32.2% (1087 of 3373). Conclusions: Our results highlight our ability to use culture-independent methods to predict antimicrobial resistance in N. gonorrhoeae .